BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 201683)

  • 1. Elevation of the cyclic GMP concentration in human platelets by sodium ascorbate and 5-hydroxytryptamine.
    Schoepflin GS; Pickett W; Austen KF; Goetzl EJ
    J Cyclic Nucleotide Res; 1977 Oct; 3(5):355-65. PubMed ID: 201683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cyclic 3',5'-guanosine monophosphate on human platelet function.
    Chiang TM; Dixit SN; Kang AH
    J Lab Clin Med; 1976 Aug; 88(2):215-21. PubMed ID: 182889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by non-steroidal anti-inflammatory agents of the ascorbate-induced elevations of platelet cyclic AMP levels.
    Pickett WC; Austen KF; Goetzl EJ
    J Cyclic Nucleotide Res; 1979; 5(3):197-209. PubMed ID: 90062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The involvement of prostaglandin endoperoxide formation in the elevation of cyclic GMP levels during platelet aggregation.
    Glass DB; Gerrard JM; Townsend D; Carr DW; White JG; Goldberg ND
    J Cyclic Nucleotide Res; 1977 Feb; 3(1):37-44. PubMed ID: 191476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of extracellular cGMP in blood mononuclear and platelet cell preparations.
    Williams WR; Kagamimori S; Davies BH; Watanabe M
    J Clin Lab Immunol; 1986 Jun; 20(2):89-92. PubMed ID: 3016277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ascorbic acid and sodium ascorbate on cyclic nucleotide metabolism in human lymphocytes.
    Atkinson JP; Weiss A; Ito M; Kelly J; Parker CW
    J Cyclic Nucleotide Res; 1979; 5(2):107-23. PubMed ID: 36416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mepacrine-induced elevation of cyclic GMP levels and acceleration of reversal of ADP-induced aggregation in washed rabbit platelets.
    Matsuoka I; Suzuki T
    J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(4-5):341-53. PubMed ID: 6147364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efflux of cyclic GMP from activated human platelets.
    Wu XB; Brüne B; Von Appen F; Ullrich V
    Mol Pharmacol; 1993 Apr; 43(4):564-8. PubMed ID: 8386309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of beta 2-glycoprotein-I upon the content of cAMP and cGMP in human blood platelets.
    Nimpf J; Gries A; Wurm H; Kostner GM
    Thromb Haemost; 1985 Dec; 54(4):824-7. PubMed ID: 3003956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of protopine on rabbit platelet function].
    Ma GY; Zhang ZZ; Chen ZH
    Zhongguo Yao Li Xue Bao; 1994 Jul; 15(4):367-71. PubMed ID: 7801784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditions influencing platelet lysis.
    Kinlough-Rathbone RL; Chahil AMAR ; Packham MA; Mustard JF
    Lab Invest; 1975 Mar; 32(3):352-8. PubMed ID: 1123914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
    Liao CH; Cheng JT; Teng CM
    Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of magnesium lithospermate B on aggregation and 5-HT release in rabbit washed platelets.
    Wang W; Wang YP; Sun WK; Xu YM; Xuan LJ
    Acta Pharmacol Sin; 2000 Sep; 21(9):859-63. PubMed ID: 11501172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin-stimulated phospholipase C activity is inhibited without visible delay by a rapid increase in the cyclic GMP levels induced by sodium nitroprusside.
    Azula FJ; Alzola ES; Conde M; Trueba M; Macarulla JM; Marino A
    Mol Pharmacol; 1996 Aug; 50(2):367-79. PubMed ID: 8700145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calcium-blocking effect of nitro compounds in human platelets: correlation with changes in the cyclic guanosine monophosphate level].
    Men'shikov MIu; Baldenkov GN; Negresku EV; Mazaev AV; Tkachuk VA
    Biokhimiia; 1987 Mar; 52(3):430-6. PubMed ID: 3034339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neither endogenous nor inhaled nitric oxide influences the function of circulating platelets in healthy volunteers.
    Albert J; Wall n NH; Li N; Frostell C; Hjemdahl P
    Clin Sci (Lond); 1999 Sep; 97(3):345-53. PubMed ID: 10464060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of halofenate--free acid on aggregation--the release reaction, coagulant activity, and lipid metabolism of human platelets.
    Huzoor-Akbar ; Ardlie NG
    Thromb Haemost; 1977 Oct; 38(3):612-9. PubMed ID: 579507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: Cyclic GMP formation in human platelets.
    Jakobs KH; Böhme E; Mocikat S
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R40. PubMed ID: 4152362
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.